Search

Ewoud van Tricht explores three novel methods that could streamline the development of adenovirus vaccines for COVID-19 at Janssen.

Facilities must be flexible enough to cope with multiple modalities, including cell and gene therapies.

We sit down with the British Generics Manufacturers Association's Warwick Smith.

Big Data opens the door to even smarter cell therapies.

Sitting down with Janssen's David Lee to discuss a new era in immunology R&D.

What factors are driving pharma's move towards digital marketing?

The advanced medicine field is progressing at breakneck speed, but we must move forward with the needs of the patient in mind.

A decade-long AAV gene therapy study in dogs emphasizes the importance of long-term follow up.

As part of the CPhI Festival of Pharma 2020, we brought together experts from our annual Power List to discuss the impact of COVID-19 on the industry.

Tissue engineers combine plant and human cells for biomedical applications.